Developments in DMD Treatment: The First Nonsteroidal Drug Approval

Explore the data that led to the FDA approval of givinostat, the first nonsteroidal treatment option for patients with duchenne muscular dystrophy.

ReachMD Healthcare Image
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free